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Introduction
The iCare TA01i (Icare Finland Oy, Helsinki, Finland) rebound tonometer is a relatively recent addition to the portfolio of tonometers currently available to the ophthalmic practitioner for measuring intraocular pressure (IOP). Hitherto, studies have shown that the rebound tonometer performs adequately as a screening tool in comparison to the Goldmann applanation tonometer (GAT; Clement Clarke International, Harlow, UK) and other handheld tonometry devices [1] [2] [3] [4] .
In brief, the iCare TA01i rebound tonometer comprises a solenoid and housing, a magnetised probe, and other associated electronics. The probe is 40 mm long, 0.3 mm in diameter with a 1.7 mm diameter plastic end-tip [5] . The device employs a solenoid to fire the probe to travel towards the cornea at a velocity of approximately 0.2 m/s. Following the propulsion pulse, electronics switch to monitor the voltage induced in the solenoid coil by the movement of the magnetised probe, allowing the speed and direction of probe movement to be monitored. Signal processing electronics and microcontrollers then derive the probe deceleration time on corneal impact and convert this to a measure of IOP.
As the iCare probe has a small footprint, it is possible to measure IOP in a number of corneal positions; this is particularly useful in the presence of central corneal abnormalities. What remains equivocal, however, is the impact of probe-cornea misalignments on the resultant IOP reading. Previous studies have attempted to elucidate these putative erroneous errors; however, to date, these studies have generally neglected to examine the central 4 mm corneal zone within which most readings would normally be acquired, clinically. Instead, studies have measured IOP at positions 2 mm from the limbus [6] [7] [8] . Further, the exact methods adopted to adjust probe position in relation to the cornea are often an approximation using rudimentary techniques [9, 10] and they generally lack any real quantifiable level of precision and accuracy [11] .
The aim of the present study, therefore, was to assess the impact of iCare TA01i probe-cornea misalignments on IOP using a bespoke alignment rig with a high level of positional accuracy and precision. Here, measurements were acquired with horizontal angular deviations at 5 ∘ and 10 ∘ , both nasally and temporally. Further, in contrast to previous research, lateral misalignments were assessed within the central 4 mm corneal zone.
Methods
Data were collected from the right eyes of 36 healthy subjects (16 men and 20 women) aged from 17 to 49 years (mean ± SD 24.3 ± 7.6 years). Informed consent was obtained from each subject, and the research followed the tenets of the Declaration of Helsinki. The School of Life and Health Sciences Human Ethics Committee at Aston University, Birmingham, United Kingdom, approved all procedures.
IOP measurements were initially taken with the iCare tonometer. For the purpose of this study, the iCare was mounted onto a slit lamp base containing a bespoke alignment rig with six degrees of freedom, thus enabling precise and accurate manipulation of the probe position. The micrometer scales used to modify the tonometer's position in relation to the cornea afforded a 0.01 mm level of precision for linear displacements and 1 ∘ for angular deviations (see Figure 1 ). With the subjects seated, relaxed, and resting their heads on the slit lamp, baseline IOP measurements were acquired with the tip of the disposable iCare probe aligned normal to the corneal apex and 5 mm away from the anterior corneal pole; this distance was measured using the vertex distance scale mounted on an Oculus Universal Spring Cell Trial Frame (OCULUS Optikgeräte GmbH, Münchholzhäuser, Germany), which was worn for the entire duration of all iCare measurements to enable continuous monitoring of the eyeprobe alignment.
To determine the effect of probe misalignments, IOP was measured with the iCare tonometer in multiple positions. Horizontal angular deviations included 5
, and 10 ∘ temporally (10 ∘ T). In addition, the iCare probe was deviated laterally by ±2 mm nasally (2N) and temporally (2T). The sequence of data collection was randomised to control for the potential effect of measurement order. For all positions, three repeats of six consecutive readings were taken with the same iCare probe and averaged.
On completion of all iCare IOP readings, GAT measurements were taken. The GAT is currently the clinical gold standard for measuring IOP [12] and has been described in detail elsewhere [13] . Disposable Tonosafe probes were used for all GAT readings, a protocol adopted in previous investigations [5, 14] , as repeated use of the original probe would otherwise require time-consuming sterilization procedures, unsuitable for the present study. Following a slit lamp examination of the anterior corneal surface, one drop of 0.5% proxymetacaine and 0.25% fluorescein (Minims, Bausch & Lomb Pharmaceuticals, Inc., FL, USA) was instilled into the right eye of each subject.
A second UK-registered optometrist, who was blind to the tonometer scale and to the iCare baseline readings, took GAT measures. All tonometry readings were acquired within a 20-minute interval thus reducing the effect of diurnal changes [15] . Again, a thorough slit lamp examination was conducted following the procedure.
Statistical Analysis.
All statistical analysis was carried out using SigmaPlot (version 12; Systat Software UK Ltd., London, UK) and SPSS for Windows (version 15; SPSS Inc., Chicago, IL, USA). All data were assessed to confirm normality (using the Kolmogorov-Smirnov test). A probability of <0.05 was taken as statistically significant. Differences in IOP measurements with the two instruments were calculated by subtracting the values obtained with the Goldmann tonometer from those obtained with the iCare tonometer. In addition, variations in iCare IOP values with probe deviation in angle and position were calculated. Paired two-tailedtests were used to determine any bias between the methods [16] . Limits of agreement between measurements made with GAT and iCare tonometer were expressed at the 95% level (mean of the difference ± 1.96 SD of the differences) and were also calculated as recommended by Bland and Altman [17, 18] .
Results

iCare Measurements at CC versus GAT.
The mean IOP ± SD, as measured by GAT, was 14.7 ± 2.5 mmHg versus central iCare tonometer readings of 17.4 ± 3.6 mmHg and represents a significant positive correlation ( = 0.446; < 0.001) with an overestimate of 2.7 ± 2.8 mmHg (paired -test: = 5.628, < 0.001) the bias of which increased at higher IOPs (see Figure 2 ). with central corneal apex measures of 0.8 ± 2.1 mmHg (see Figure 3) . Analysis showed no significant correlation between iCare tonometer measures of IOP at CC and those taken at a lateral deviation of 2 mm nasally ( = 0.079, = 0.646) nor when measured 2 mm temporally ( = 0.171, = 0.319) (see Figure 4) . For angular deviations, analysis showed no significant correlation between iCare tonometer measures of IOP at CC and those taken at 5 ∘ T ( = 0.289, = 0.088), 10 ∘ T ( = 0.047, = 0.785), 5N ( = 0.118, = 0.493), and 10 ∘ N ( = 0.103, = 0.549) (see Figure 5 ).
iCare Measurements at CC versus Specified
Discussion
The purpose of the present study was to determine the effect of specified lateral and angular deviations of the iCare tonometer probe on the accuracy of IOP measurement as compared to readings in the optimal position, namely, the central corneal apex; this is the first time that a study of this type has used a bespoke rig to carefully control the desired iCare tonometer probe positions. Further, the relatively small lateral and angular deviations specified in the present study, confined to the central 4 mm zone, were chosen to assimilate the typical misalignments that could occur in everyday clinical practice. IOP measurements taken at the central corneal apex were also compared to the current clinical gold standard, the Goldmann applanation tonometer, in normal, healthy subjects.
The present study has confirmed, in broad agreement with earlier work [11, 19, 20] , that in comparison to GAT, the iCare tonometer overestimates IOP, with this bias widening at higher readings. That is to say, the iCare overestimates IOP for patients with higher IOP values.
For lateral deviations, the iCare tonometer readings were marginally lower than those at the central corneal apex (see Figure 3 ) but not at levels of statistical significance either at nasal or temporal eccentricities. Similarly, for angular deviations of 5 and 10 degrees temporally, and 5 degrees nasally, iCare tonometer readings were lower than readings with the instrument in its optimal position, but not reaching levels of statistical significance. However, when the iCare tonometer probe was deviated 10 degrees nasally, the underestimate of IOP did reach a significant level statistically, although this <1 mmHg difference is of little consequence in a clinical context considering the intrasubject variability of Goldmanntype tonometers [21] .
A principal advantage of the iCare rebound tonometer is its ability to measure IOP in patients who are supine at the time of examination. Although our device was able to control accurately the position of the upright iCare tonometer, our study did not examine the influence of patient position on the resultant IOP value. A further study, therefore, is indicated to examine the influence of probe position (upright versus horizontal) on IOP readings in healthy and diseased eyes. In this regard, it would also be interesting to examine patients with corneal pathology (e.g., band keratopathy), which may, 
Conclusions
The present study has shown that the iCare tonometer is clinically robust to small but tangible lateral and angular deviations that can occur during the use of a handheld instrument in general ophthalmic practice.
